Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georges Noel

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
EMBO Molecular Medicine|March 31, 2026
Tenascin-C orchestrates radiotherapy-induced head and neck tumor regressionThomas Loustau, Ioanna Mitrentsi, Nuohan Wang, et al.
Neuro-Oncology|July 18, 2015
Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohortJohan Pallud, Etienne Audureau, Georges Noel, et al.
Journal of Neuro-Oncology|November 22, 2017
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based modelEtienne Audureau, Anaïs Chivet, Renata Ursu, et al.
Neurosurgery|October 30, 2025
Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter StudyCharles-Henry Mallereau, Guillaume Virbel, Johan Pallud, et al.
Neuro-Oncology|July 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigationFlorien W Boele, Sé M Frances, Amélie Darlix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Plos One|October 17, 2012
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomasAhmed Idbaih, François Ducray, Caroline Dehais, et al.
Neurology|September 20, 2015
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasAgustí Alentorn, Caroline Dehais, François Ducray, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
EMBO Molecular Medicine|March 31, 2026
Tenascin-C orchestrates radiotherapy-induced head and neck tumor regressionThomas Loustau, Ioanna Mitrentsi, Nuohan Wang, et al.
Neuro-Oncology|July 18, 2015
Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohortJohan Pallud, Etienne Audureau, Georges Noel, et al.
Journal of Neuro-Oncology|November 22, 2017
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based modelEtienne Audureau, Anaïs Chivet, Renata Ursu, et al.
Neurosurgery|October 30, 2025
Long-Term Quality of Life and Functional Outcome Analysis of Surgically Managed Central Neurocytoma Patients: Results of a Multicenter StudyCharles-Henry Mallereau, Guillaume Virbel, Johan Pallud, et al.
Neuro-Oncology|July 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: an international cross-sectional investigationFlorien W Boele, Sé M Frances, Amélie Darlix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaSalah Eddine O Kacimi, Caroline Dehais, Loïc Feuvret, et al.
Plos One|October 17, 2012
SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomasAhmed Idbaih, François Ducray, Caroline Dehais, et al.
Neurology|September 20, 2015
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasAgustí Alentorn, Caroline Dehais, François Ducray, et al.
Pageof 10